Long-term bone marrow cultures (LTBMCs) were grown according to a standard assay from 10 7 bone marrow mononuclear cells in 10 mL Iscove's modified Dulbecco's medium supplemented with 10% fetal bovine serum (FBS; Gibco), 10% horse serum (Gibco), 2 mmol L-glutamine (Gibco), 100 IU/mL penicillin/streptomycin, and 10 -6 mol hydrocortisone sodium succinate (Sigma-Aldrich), and incubated at 33°C in 5% CO2 in a fully humidified atmosphere.
Flow-cytometric analysis of TLR expression
To evaluate surface TLR1, TLR2, TLR4 and intracellular TLR3 and TLR9 expression in the CD14 + monocyte cell fraction of bone marrow cells, we performed three-color flow-cytometry using a panel of directly conjugated monoclonal antibodies in an Epics Elite flow-cytometer (Coulter, Miami, FL, USA). The surface and intracellular staining procedures, monoclonal antibody clones and gating strategy have been previously described. 3 Surface and intracellular TLR expression were also evaluated in the CD45 + /CD14
+ and CD45 -cell fractions of trypsinized adherent cells of confluent LTBMCs, representing the monocytic and mesenchymal/stromal cell components of the marrow microenvironment, respectively.
3 Results are expressed as the proportion of TLR + cells in the above gates and also as the mean ratio of relative fluorescence intensity (MRFI) defined by the ratio of the mean fluorescence intensity (MFI) of the TLR staining/MFI of the isotype-matched monoclonal antibody staining.
Generation of bone marrow-derived macrophages
To generate bone marrow-derived macrophages, 10 7 BMMCs were cultured in 10 mL Dulbecco's modified Eagle's medium (DMEM; Gibco) supplemented with 10% FBS and 1% penicillin/streptomycin at 37ºC in 5% CO2 in a fully humidified atmosphere for 24 h. The non-adherent cells were then harvested, transferred to a 75 cm 2 tissue culture flask containing 10 mL complete DMEM supplemented with 25 ng/mL recombinant human (rh) interleukin (IL)-3 (R&D Systems, Minneapolis, USA) and 2.5 ng/mL granulocyte-macrophage colony-stimulating factor (GM-CSF; R&D Systems) and incubated for 4 days before adding another 10 mL of complete, growth factor-containing DMEM. After 15 days in culture, the purity of the adherent macrophages was more than 90% as determined by flow-cytometric determination of CD14 antigen expression (clone RMO52; Beckman Coulter, Marseille, France).
Phagocytosis assay
Autologous non-adherent BMMCs seeded in RPMI-1640 medium (Gibco) supplemented with 10% FBS and 1% penicillin/streptomycin for 15 days, were labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE) (CellTrace™ CFSE Cell Proliferation Kit, Invitrogen) and incubated with 30 μg/mL etoposide 4 for 5 h so that more than 75% of cells became apoptotic as determined by flow-cytometry and staining with 7-amino-actinomycin D (7AAD) (Calbiochem-Novabiochem, La Jolla, CA, USA).
2 Titration experiments were performed to determine the dosage of the drug needed to achieve the desirable proportion of apoptosis. Apoptotic cells were then added to the macrophage monolayers at a 4:1 ratio (target cell: macrophage) and co-incubated for 35 min at 37°C in 5% CO2 in a fully humidified atmosphere. At the end of the incubation period, macrophages were washed three times to remove noninternalized cells, fixed with 4% paraformaldehyde and stained with fluorescein isothiocyanate-conjugated anti-CD14 monoclonal antibody and 4',6-diamidino-2-phenylindole (DAPI, Abbott Laboratories, Illinois, USA). Under fluorescence microscopy, macrophages appear green while apoptotic cells show intense green fluorescence (Online Supplementary Figure  S1 ). The phagocytic/efferocytic index was calculated after examining blindly 200 macrophages under the fluorescent microscope using the formula [(number of apoptotic bodies/200 total macrophages) x 100]. 5 The examination was performed by two independent observers.
Reverse transcription and quantitative polymerase chain reaction analysis
Total RNA was extracted from immunomagnetically sorted CD14 + cells (Mitenyi Biotec GmbH, Bergisch Gladbach, Germany) derived from the BMMC cell fraction using the RNeasy Mini Kit (Qiagen GmbH, Hilden, Germany). The concentration of the extracted RNA was calculated by the Qubit Fluorometer (Invitrogen). RNA was reverse transcribed with the SuperScript First-Strand Synthesis System (Invitrogen).
Quantitative SYBR green-based real-time polymerase chain reaction (PCR) analysis of 84 genes related to TLR-mediated signal transduction was performed using the human Toll-Like Receptor Signaling Pathway RT 2 Profiler TM PCR Array (SABiosciences, Qiagen) in an ABI Prism 7000 System (Applied Biosystems, Foster City, CA, USA). The expression of each gene was calculated according to the threshold cycle (Ct) relative quantification 2 -ΔCT method, using the ribosomal protein L13a (RPL13A) as a housekeeping gene for normalization. For the genes showing at least a 4-fold difference in gene expression between test and control groups we performed a gene set enrichment analysis using the tool GOrilla 6 . This tool uses the Gene Ontology database to obtain sets of genes which are significantly enriched in specific molecular functions, biological processes and cellular components.
To confirm the results obtained from the PCR array, a number of significantly over-expressed genes were tested separately by quantitative reverse transcription PCR using primers purchased from SABiosciences. We also examined the expression of interleukin-1 receptor-associated kinase (IRAK)-M and SH2 domain containing polyinositol-5-phosphatase 1 (SHIP1) genes that negatively affect TLR signaling 7,8 and were not included in the array. For IRAKM the sense primer was 5'-TTTGAATGCAGCCAGTCTGA-3' and the antisense 5'-GCATTGCTTATGGAGCCAAT-3'; for SHIP1 the sense primer was 5'-CGACAAGAAGCTGAGTCCCTTT-3' and the antisense 5'-GGTAGTTAAGATCCCCAAACCAGAA-3'. All samples were run in triplicate. A 2-fold serial dilution of cDNA from a healthy individual was selected as a calibrator for quantification of the selected genes according to the 2 -ΔCT method. Online Supplementary Figure S1 . Fluorescent microscopy-based phagocytic assay for the evaluation of the apoptotic cell clearance rate of BM macrophages. BM-derived macrophages from five MDS patients and five healthy donors were incubated with CFSElabeled apoptotic BMMCs (ratio 1:4) at 37ºC and then stained with CD14-FITC and DAPI. Online Supplementary Figure S2 . Clonogenic potential of normal CD34 + cells in the presence of apoptotic cells or HMGB1. Irradiated macrophage layers from MDS patients (n=6) or healthy subjects (n=6) were recharged with 2x10 4 allogeneic normal CD34 + BM cells in the presence or absence of 2x10 6 apoptotic or live allogeneic normal peripheral blood mononuclear cells (PBMCs) in the presence or not of a TLR4 blocking monoclonal antiboby. The clonogenic potential of the nonadherent cell fraction containing the CD34 + cells was assessed in a week's time by scoring the total colonies, characterized as total colony-forming cells (CFC). (A) Columns represent the mean (plus one standard deviation) of CFC numbers produced by the non-adherent cells of recharged MDS-derived macrophage culture cells in the presence or absence of either apoptotic or live allogeneic PBMC with or without the addition of a specific TLR4-inhibitor. (B) The graph depicts the mean CFC numbers (plus one standard deviation) produced by the nonadherent cells of recharged macrophage cultures derived from healthy subjects following treatment with apoptotic cells in the presence or absence of a specific TLR4-inhibitor. The fourth bar depicts CFC produced by the non-adherent cells of normal macrophage cultures assessed in the presence of a higher concentration (HC) of apoptotic PBMC (4x10 6 ). (C) The bars represent the mean CFC numbers (plus one standard deviation) in the non-adherent cell fraction of normal macrophage cultures recharged with allogeneic normal CD34 + BM cells in the presence or absence of recombinant human (rh) HMGB1 at a concentration of 300 ng/mL corresponding to the mean cytokine levels measured in the BM plasma of MDS patients. In all cases comparisons were performed using the non-parametric Wilcoxon signed rank test for paired samples and the P values are indicated. N.S. denotes a non-statistically significant difference.
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Online Supplementary Table S3 . TLR-signaling related genes showing at least a 4-fold up-regulation in MDS CD14 + BM cells.
Functional characterization of genes Genes
Toll-like receptors TLR1, TLR2, TLR3, TLR4, TLR5, TLR6, TLR7, TLR8, TLR9, CD180 (LY64), SIGIRR Adaptor and interacting proteins CD14, HSPD1, LY86 (MD-1), MAPK8IP3, MYD88, , RIPK2 , TICAM2, TOLLIP  Effectors  CASP8, EIF2AK2, FADD, IRAK1, IRAK2, PPARA, TRAF6, UBE2V1  TLR signaling  Negative regulation  SIGIRR  MYD88-independent pathway  NR2C2, PELI1, TBK1, TICAM2, TICAM1, TRAF6, TLR4, TLR3  MYD88-dependent pathway  IRAK1, IRAK2, MYD88, NR2C2, TLR1, TLR2, TLR4, TLR5, TLR6, TLR7, TLR8, TLR9, Online Supplementary Table S2 . TLR expression in the BM and LTBMC adherent cell subsets of MDS patients.
